Cargando…
Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12)
BACKGROUND: Most patients with cancers of the nasal cavity or paranasal sinuses are candidates of radiation therapy either due incomplete resection or technical inoperability. Local control in this disease is dose dependent but technically challenging due to close proximity of critical organs and ac...
Autores principales: | Jensen, Alexandra D, Nikoghosyan, Anna V, Windemuth-Kieselbach, Christine, Debus, Jürgen, Münter, Marc W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112165/ https://www.ncbi.nlm.nih.gov/pubmed/21600049 http://dx.doi.org/10.1186/1471-2407-11-190 |
Ejemplares similares
-
Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC
por: Jensen, Alexandra D, et al.
Publicado: (2010) -
IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial
por: Jensen, Alexandra D, et al.
Publicado: (2012) -
Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux(® )and particle therapy]
por: Jensen, Alexandra D, et al.
Publicado: (2011) -
Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT
por: Jensen, Alexandra D, et al.
Publicado: (2011) -
Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity
por: Jensen, Alexandra D, et al.
Publicado: (2011)